GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for phosphoenolpyruvate carboxykinase (ATP) (Q7NA45)

Analyse AlphaFold monomer V2.0 prediction for phosphoenolpyruvate carboxykinase (ATP)… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q7NA45
Type
protein
Length
539 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x92eF3937744b956cB1E76Cc4107c8FF17A74F07d
Molecule
Phosphoenolpyruvate carboxykinase (ATP)
UniProt
Q7NA45
Pockets
4 · best druggability 0.72

Structure

1 distinct chain · 31% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphoenolpyruvate carboxykinase (ATP)protein53931% helix, 24% strandQ7NA45

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14870.720.8167empty
2910.370.7620empty
3550.360.7814empty
4640.340.7612empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.